Matthew Beatty
Publications by Year
Research Areas
Immunotherapy and Immune Responses, CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Cancer Research and Treatments, Immune Cell Function and Interaction
Most-Cited Works
- → T-cells produce acidic niches in lymph nodes to suppress their own effector functions(2020)148 cited
- → HDAC11 deficiency disrupts oncogene-induced hematopoiesis in myeloproliferative neoplasms(2019)60 cited
- → Expansion of tumor infiltrating lymphocytes (TIL) from bladder cancer(2018)52 cited
- → Reactive Myelopoiesis Triggered by Lymphodepleting Chemotherapy Limits the Efficacy of Adoptive T Cell Therapy(2020)49 cited
- → Ligand-mediated protein degradation reveals functional conservation among sequence variants of the CUL4-type E3 ligase substrate receptor cereblon(2018)49 cited
- → Fucosylation of HLA-DRB1 regulates CD4+ T cell-mediated anti-melanoma immunity and enhances immunotherapy efficacy(2023)48 cited
- → Expanded Tumor-infiltrating Lymphocytes From Soft Tissue Sarcoma Have Tumor-specific Function(2021)46 cited
- → Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma(2022)35 cited
- → Neoantigen-specific CD4+ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients(2023)33 cited
- → Expansion of tumor-infiltrating lymphocytes (TIL) from penile cancer patients(2021)33 cited